Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $115.0800 (-2.75%) ($114.9200 - $119.0800) on Thu. Jun. 9, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.95% (three month average) | RSI | 48 | Latest Price | $115.0800(-2.75%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.7% a day on average for past five trading days. | Weekly Trend | LGND declines -1.3% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) XBI(56%) IWO(55%) IWC(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -0.975% in a week (0% probabilities). VIXM(-15%) TLT(-15%) UUP(-8%) GDXJ(-5%) IPO(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.975% (StdDev 1.95%) | Hourly BBV | 0 () | Intraday Trend | -2.6% | | | |
|
Resistance Level | $118.73 | 5 Day Moving Average | $116.69(-1.38%) | 10 Day Moving Average | $118.35(-2.76%) | 20 Day Moving Average | $118.73(-3.07%) | To recent high | -11.7% | To recent low | 18.5% | Market Cap | $1.849b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |